Headway
Headway runs an insurance network connecting therapists with patients using insurance.
On the record
Checkpoint: Resolution of PHI data-sharing class action (A.G. v. TherapyMatch) and next funding round
The call
Headway has scale and payer relationships but trails Rula on revenue, leaving its claim to category leadership unsettled.
Headway is an online therapy platform that matches people with licensed counselors and handles insurance payments, which requires jumping through legal and insurance-company hoops that are hard but not impossible to clear. It is struggling because a rival company called Rula is bringing in nearly three times as much money, even though Headway's investors value it much higher, which suggests neither one is clearly winning yet. The biggest question mark is whether Headway can grow faster than Rula and stay ahead, plus a lawsuit about how the company shares user data could damage trust with the doctors and insurance partners it depends on.
Why
01
AI pressure: AI therapy chat apps (Woebot, Wysa) and AI intake/matching tools. AI can't bill insurance or credential therapists yet, but AI scheduling and matching tools could squeeze Headway's software layer. Could AI do the core job? Unlikely.
02
Bigger players: UnitedHealth/Optum and Rula. Optum already runs its own behavioral network, and Rula reportedly pulls in about $471M in revenue versus Headway's roughly $160M. Could a giant copy it? Probably.
03
What protects it. Insurance credentialing and payer contracts take years to build, so switching networks is slow even when a rival grows faster.
What would change this call
Headway discloses or leaks audited 2025/2026 revenue figures. Would confirm or refute whether it still trails Rula in scale.
Outcome of the LinkedIn-pixel PHI data-sharing class action (N.D. Ill.). Material damages could damage payer trust central to its moat.
Announcement of a new exclusive or preferred payer contract (e.g., UnitedHealth, Aetna, BCBS). Would show Headway gaining an edge peers like Rula and Alma cannot match.
Outcome of the LinkedIn-pixel PHI data-sharing class action (N.D. Ill.). Material damages could damage payer trust central to its moat.
Announcement of a new exclusive or preferred payer contract (e.g., UnitedHealth, Aetna, BCBS). Would show Headway gaining an edge peers like Rula and Alma cannot match.
Key numbers
- Headway revenue ~$160M vs Rula's ~$471M
- 60,000+ providers in network
- $2.3B valuation on $325.5M raised
Named risks
- PHI-sharing class action alleging LinkedIn tracking pixel data leaks, filed Sep 2024, N.D. Ill.
- California wage-and-hour class action over alleged overtime violations, pending Oct 2025.
- BBB complaint pattern alleging deceptive '$0 estimated cost' billing followed by surprise charges, 2026.
- Revenue and growth trailing peer Rula ($471M vs Headway's smaller reported scale) in a fragmented category.
- Sector-wide scrutiny of practice-management platforms as insurer-aligned, eroding clinician autonomy, per journalism/advocacy research 2026.
Rivals, as read in July 2026
| Rival | Direction | Evidence |
|---|---|---|
| Rula | losing to | Rula hit ~$471M annualized revenue in 2024, up 100% YoY, per Sacra, 2025-09-02 |
| Alma | contesting | Alma has ~24,000 providers but does not accept Medicare/Medicaid, per Rula comparison, 2026-06-03 |
| Grow Therapy | contesting | Grow Therapy has ~23,000 providers and broader Medicare/Medicaid coverage, per Rula comparison, 2026-05-12 |
| Large insurers (UnitedHealth/Optum, Cigna/Evernorth, BCBS licensees) | gaining on | Insurers control network access and directory rules; HCSC invested in Headway rather than competing directly, 2023-10-04 |
Questions people ask
- Is Headway profitable in 2026?
- Headway has not disclosed profitability. It raised a $100M Series D at a $2.3B valuation on 2024-07-23 led by Spark Capital, and total funding across five rounds is about $325.5M, but no public revenue or profit figures have been confirmed by the company.
- Who owns Headway and who has invested in it?
- Headway is privately held and VC-backed, with no IPO or acquisition. Its Series D closed 2024-07-23 for $100M at a $2.3B valuation, led by Spark Capital; other investors include a16z, Accel, GV, Thrive Capital, and Health Care Service Corporation, a Blue Cross Blue Shield licensee.
- Is Rula a bigger competitor than Headway?
- Rula reportedly generated about $471M in annualized revenue in 2024, up 100% year over year, per Sacra research published 2025-09-02. Headway and Rula both operate insurance-enabled therapist marketplaces and compete for the same providers and payer contracts.
- Could AI replace Headway's therapists or the company itself?
- AI is being applied to back-office tasks like clinical notes and scheduling; Headway acquired the Tezi AI team on 2026-03-31 to automate administrative workflows. Actual therapy delivery still requires licensed human clinicians and insurer credentialing, which AI alone cannot replace.
- Is Headway facing any lawsuits?
- Yes. A putative class action, A.G. v. TherapyMatch, was filed in N.D. Illinois in September 2024 alleging Headway shared patient PHI with LinkedIn via tracking pixels. A separate California wage-and-hour class action, Brower-Walsh v. Therapy Match, was pending as of October 2025.
- How large is Headway's provider network?
- Headway's network grew from 25,000 providers in October 2023 to 34,000 in July 2024 and surpassed 60,000 by mid-2025/2026, per company and BuiltIn data, operating across all 50 US states plus Washington DC.
Timeline
- 2026-03-31Headway acquires Tezi AI team, names cofounder Raghavendra Prabhu VP of Engineering
- 2025-09Headway announces AI-assisted clinical note generation for insurer submission
- 2025-05-13Nationwide primary-care referral integration launches, reaching 15,000 physicians
- 2024-09Class action A.G. v. TherapyMatch filed in N.D. Illinois over alleged LinkedIn PHI sharing
- 2024-07-23Series D closes at $100M, valuing Headway at $2.3B, led by Spark Capital
- 2023-10-04Series C closes at $125M, valuing Headway at $1B, with HCSC participating
- 2021-05-03Series B raises $70M at a $750M valuation, led by a16z
- 2020-11-17Headway announces Series A funding of $26M
- 2019Headway founded by Andrew Adams, Dan Ross/Saper, Jake Sussman, and Kevin Chan
Revision history
22 July 2026
First assessed. Losing its protection. The text above is fixed as of this date and is not edited afterwards.
In the same band
Sources
- Introducing Headway (2020-11-17)
- Headway Raises $100 Million in Series D Funding (2024-07-23)
- US mental health startup Headway raises $125 million at $1 billion valuation (2023-10-04)
- Headway Revenue, Valuation & Funding History (2025) (2025-11-23)
- Headway Careers, Perks + Culture (2026-05-21)
- Working at Headway (NY) (2026-07-05)
- Sacra (2024-08-28)
- Headway launches nationwide solution to bridge the primary care-mental health divide (2025-05-13)
- Rula at $471M/year growing 100% YoY (2025-09-02)
- Mental health platform Headway acquires team behind Tezi (2026-03-31)
- Headway Acquires Team Behind Tezi (2026-03-31)
- How Does Headway Make Money? (2025-02-14)